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Agnieszka Tomik, Anna Chanas, Bożena Werner●iD
Clinic of Paediatric Cardiology and General Pediatrics, Warsaw Medical University, Warszawa, Poland
Abstract
Myocarditis is defined by the World Health Organization as an inflammatory disease involving cardiomyocytes, interstitial 
tissue, vessels and occasionally the pericardium. In this article, literature from the past 5 years regarding epidemio-
logy, diagnostic tests, treatment and prognosis in myocarditis in young children and adolescents was analyzed. For this 
purpose the Pubmed database was screened using the key words “myocarditis” and “children”, yielding 117 articles. 
This list of was narrowed down to those in which the study group consisted of at least 5 people and included informa-
tion about: symptoms and signs, abnormalities in additional tests, etiology, treatment, length of hospitalization and 
mortality. Finally, the review included 17 studies, describing 1891 children with a diagnosis of myocarditis. The analysis 
shows that myocarditis is a rare disease. Two peaks of the disease are observed: the first in newborns and infants, the 
second one in adolescents. Age less than 2 years is a predictor of severe prognosis. In reported cases the most com-
mon symptoms were: fatigue, chest pain, palpitations or irregular heart rhythm. Tachycardia, tachypnoe, hypotension 
and hepatomegaly dominated among findings in physical examination. The interview, the result of physical examination 
and additional tests (troponin levels, electrocardiogram, echocardiogram) are helpful in making a diagnosis. Cardiac 
magnetic resonance imaging is used to confirm the diagnosis. In the analyzed group, 65–90% of children were treated 
in the Intensive Care Unit. Extracorporeal membrane oxygenation was used in 168 cases, a ventricular assist device was 
implanted in 35 children and 38 children underwent heart transplantation. The mortality rate in myocarditis remains 
high (25–35% in analyzed studies). Up to 25% of children may develop chronic heart failure. Due to the unpredictable 
course of this disease, patients in the acute period of the disease should be hospitalized, and after being discharge 
from the hospital undergo further cardiological check-up.
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Introduction
Myocarditis is a disease of varied etiology and course 
— from asymptomatic to fulminant — which can quickly 
lead to the death of the patient. According to the World 
Health Organization (WHO), myocarditis is defined as an 
inflammatory disease involving cardiomyocytes, intersitial 
tissues, vessels and sometimes also the pericardium. It 
is diagnosed on the basis of histological (i.e. the Dallas 
criteria), immunological (anticardiac antibodies) and im-
munohistochemical criteria.
The diagnostic procedure is based on the criteria for 
clinical suspicion of myocarditis developed by the Working 
Group on Myocardial and Pericardial Diseases of the Eu-
ropean Society of Cardiology in 2013 [1], while in cardio-
vascular magnetic resonance (CMR) myocarditis is diag-
nosed on the basis of the Lake Louis criteria [2, 3]. Treat-
ment of myocarditis should be mainly focused on inhibiting 
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cardiomyocyte damage. All patients in acute phase of the 
disease should limit their physical activity to a minimum 
(bed regime). It is believed that in myocarditis of viral etio-
logy physical effort may increase the replication of the virus. 
The mortality rate of myocarditis is high and is estimated 
at 25% in children and as much as 75% in infants [4, 5]. 
In addition, constant deterioration of myocardial function 
with progression to dilated cardiomyopathy is observed in 
approximately 25% of patients after myocarditis.
The aim of the paper was to analyze the literature on 
the course of myocarditis in children and adolescents, pub-
lished within the last 5 years.
Materials and methods
A review of a medical database, Pubmed, with the use of 
key words children and myocarditis was performed. The 
search strategy enabled the obtaining of 117 articles in 
total. The following inclusion criteria were adopted: study 
group involving at least 5 children, containing demo-
graphic data, prodromal symptoms, clinical symptoms, 
myocardial damage markers [troponin, B-type natriuretic 
peptide (BNP)/N-terminal pro-B-type natriuretic peptide 
(NT-proBNP)] and deviations in imaging: chest X-ray, 
electrocardiography (ECG)/Holter ECG, echocardiography 
(ECHO), CMR i endomyocardial biopsy (EMB), determination 
of etiological factors and description of the applied treat-
ment broken down into pharmacological treatment of heart 
failure, mechanical respiratory and circulatory support, the 
application of intravenous infusions of immunoglobulins 
(IVIg) and steroids, the time of hospitalisation and data on 
the number of deaths. Final analysis included 17 articles 
published between the years 2015 and 2020.
Results
In total, the summary covers 1,891 children diagnosed 
with myocarditis (Table 1) [6–22]. It is, therefore, a rare 
disease. It is estimated that the disease occurs in one or 
two children per 100,000 annually. Usually, two peak inci-
dences are observed. The first takes place in the neonatal 
period and early infancy, and the second — during puberty 
[6–13]. According to Rodriguez et al. [12], the age < 2 is 
a factor of poor prognosis. The disease most often affects 
boys, especially in older groups; they constitute 52–60% 
of patients. According to Matsuura et al. [14], the trend 
is not characteristic in early infancy. The cited authors 
indicate that the course of myocarditis is more severe in 
girls, and Wu et al. [15] demonstrate that extracorporeal 
membrane oxygenation [ECMO] is more frequently used 
in boys than girls.
Prodromal symptoms of acute myocarditis occur a cou-
ple or a dozen or so days earlier. As works by Howard et al. 
[12] and Rodriguez-Gonzalez et al. [13] indicate, history 
of respiratory infection or gastritis plays a very important 
role in the diagnosis of the disease. Symptoms of respira-
tory infection — cough, difficulty breathing, dyspnea — is 
observed in 57–84% of children, in 20–60%, especially 
younger ones, vomiting or other dyspeptic symptoms. Fe-
ver occured in 28–68% of patients (in 100% children with 
myocarditis, in the course of the flu). Older children had 
breathing difficulties, and in primarily reported intolerance 
to physical effort and weakness (12–73%). Chest pain 
was observed in 12–53% of patients, fainting occurred in 
1–15% and the sense of uneven heartbeat and palpitation 
was reported by 5–53% of children. On admission to hos-
pital, the most frequently observed deviations on physical 
examination were: tachypnoe 18–68% and tachycardia, 
observed in over 50% of patients, and in some groups in 
90% of patients. Other symptoms included: hypotension in 
24–51% of patients, hepatomegalia — in 28–58%, more 
rarely murmur above the heart and peripheral oedema, and 
irregular heartbeat with accompanying arrhythmia. Signs 
of cardiogenic shock and respiratory failure were observed 
in children with fulminant myocarditis.
Further proceedings in patients with suspected myocar-
ditis consisted in the estmiation of the level and severity of 
myocardial damage in subsequent examinations such as: 
myocardial damage markers, ECG, chest X-ray and ECHO. 
Determination of the concentration of troponins, released 
during cardiomyocyte damage, was necessary for the dia-
gnosis. At the time of admission, they were released in 
62–100% of children. They are observed in the majority 
of children with myocarditis, however, their presence does 
not always correlate with the degree of the damage and 
further prognosis and normal does not rule out inflam-
mation. As the observations made by Butto et al. [16] in-
dicate, children with higher troponin concentration more 
frequently required treatment with the use of ECMO, but 
there was no such correlation with the level of their mortal-
ity. The concentration of BNP or NT-pro-BNP was another 
marker of cardiovascular performance that was evaluated. 
It was significantly elevated in more than 50% of patients. 
In the assessment of Rodriguez-Gonzales et al, the values 
of NT-pro-BNP exceeding 2,000, especially 5,000 pg/mL, 
should be considered as a factor of poor prognosis [12]. 
According to clinicists, monitoring of the concentration of 
the peptide is particularly useful in the assessment of the 
applied treatment.
In approximately 90% of children hospitalized due to 
myocarditis, abnormalities in ECG were observed. Most fre-
quently, it was sinus tachycardia (in 64–85%), and in 50% 
— repolarization abnormalities [6–22]. These changes are 
similar to changes occuring in patients with acute coronary 
syndrome (ACS). Further evolution thereof is also similar. 
Other deviations recorded in ECG included: low QRS voltage 
and signs of atrial and/or ventricular hypertrophy. Abnor-
malities of the electrocardiogram are non-specific; they vary 
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in time and require repeating of the examinations in the fol-
lowing days. ECG and Holter ECG are performed in order to 
detect arrhythmia and differentiate its type. The most dan-
gerous arrhythmias in the published studies included: ven-
tricular tachycardia, requiring electric or pharmacological 
cardioversion, more rarely — supraventricular tachycardia. 
Disturbances of conduction and complete atrioventricular 
block occurred more rarely. In the group analyzed by Lv et 
al. [8], however, they occurred in 50% of children. All pa-
tients required periodic electrical stimulation.
Chest X-ray was normal in 50% of patients. In others, 
it revealed enlargement of the cardiac silhouette, more 
rarely — signs of pulmonary congestion or pleural fluid 
were observed.
ECHO, which was abnormal in 80–100% of patients, 
was of greater diagnostic value in myocarditis. The chang-
es included the enlargement of the left ventricle with 
impairment of contractility (both global and sectional), 
changes in ventricular geometry, disorders in cardiac wall 
movement, mitral regurgitation or presence of fluid in the 
pericardial sac. It is significant that thickening of the myo-
cardial walls, while the size of the ventricle remained nor-
mal, was observed in some patients with fulminant myo-
carditis [8, 11]. Echocardiographic imaging is, therefore, 
non-specific, and ECHO, particularly in little children, is 
helpful in differential diagnosis of heart failure in terms 
of the exclusion of such causes as, for example, congeni-
tal coronary artery defect. 
In order to unambiguously confirm the disease in adults, 
myocardial biopsy is recommended [1]. However, as an in-
vasive examination, requiring cardiac catherization in gen-
eral anaesthesia, it is performed less and less frequently. 
According to the reports, in the case of fulminant myocar-
ditis, it was performed in 26% of children in the United 
State of America (USA), in 11% in Japan, in 50% of chil-
dren in Germany, in 35% of children in the United Kingdom 
[6, 14, 17]. It is currently performed mainly in the case of 
the symptoms of acute heart failure resistant to pharma-
cological treatment, simultaneously with the implantation 
of myocardial support devices). According to the literature, 
EMB complications concern 1–16% children, and they 
reach 40% in small infants [23].
CMR is the current “gold standard” in myocarditis dia-
gnosis in children. The examination, however, was not 
broadly available and was not performed in all analyzed 
groups. In centres where it was possible, it was performed 
in 20–80% of patients. According to the researchers, the 
most typical sign of active myocarditis is the presence of 
late post-contrast enhancement and tissue edema located 
intramuscularly or subepicardially [24]. In older children 
with clinical suspicion of acute myocarditis and history of 
myocarditis, CMR should constitute the first line examina-
tion. The necessity of the application of general anaes-
thesia in hemodynamically unstable patients constitutes 
a certain limitation in small children. In the study groups, 
diagnosis was frequently made without EMB/CMR, on the 
basis of clinical data and abnormalities in laboratory tests, 
ECG and/or ECHO, after other causes were ruled out.
The conducted studies confirm the current data pro-
viding that the most frequent cause of myocarditis in chil-
dren are viral infections [25]. The most frequently detected 
ones included entero(Coxackie grup B)-, echo- and adeno-
viruses in the USA, and herpesviruses [e.g. human herpes-
virus 6 (HHV6)] and parvovirus B19 in Europe. In the ana-
lyzed groups, the etiology was determined in the analysed 
groups. It has recently been observed that myocarditis 
occurs in severe acute respiratory syndrome coronavirus 
(SARS-CoV-2) infection as well, also in the absence of re-
spiratory symptoms characteristic of coronavirus disease 
2019 (COVID-19) [26].
Due to the necessity of constant monitoring of car-
diovascular performance parameters, all children with 
myocarditis were hospitalized. The higher percentage of 
children in the Intensive Care Units, ranging from 14- to, 
more frequently, 65–90%, proves the severity of the dise-
ase. Most of these children required respiratory support as 
well as intravenous inotropic medication, such as catechol 
amines and/or phosphodiesterase inhibitors. Apart from 
bed regime, more than 50% of children were treated with 
diuretics, angiotensin converting enzyme (ACE) inhibitors 
and beta-blockers. In some centres, mostly American and 
Asian, intravenous immunoglobulin infusions or steroids 
administered intravenously or systemically were applied. 
However, no significant impact on the course of the disease 
and mortality was observed [27–30].
If the patient remained unstable despite pharmaco-
logical treatment, mechanical circulatory support was 
implemented [7, 31]. ECMO was applied in 168 children, 
Which constituted, depending on the described group, from 
17–41% of patients, especially with fulminant myocarditis 
[6, 7, 16]. According to Wu et al. [15] from Taiwan, female 
sex, vomiting, seizures and, primarily, ventricular tachycar-
dia and decreased ejection fraction of the left ventricle as 
well as higher concentrations of troponins occurred signifi-
cantly more frequently in the group of children requiring 
ECMO [15] Typical mechanical cardiovascular support, the 
so-called ventricular assist devices (VAD) were temporarily 
implanted in 35 patients. Children with complete atrioven-
tricular block required period transvenous stimulation, and 
children with ventricular tachycardia required electric car-
dioversion. Single patients had implantable cardioverter- 
-defibrillator (ICD) implanted.
In the group of 1,891 patients, heart transplant was 
performed in 38 children, mainly in the USA. Single trans-
plants were carried out in Germany and Japan [6, 7, 14].
The period of hospitalisation ranged from 6 to 35 days. 
Depending on the group, from several to even 35–40% of 
children died. Most children recovered completely from 
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myocarditis, however, approximately 25% of patients myo-
cardial dysfunction was present on the day of discharge. 
Given the lack of data, further course of the disease can-
not be evaluated on the basis of the above-cited studies. 
All authors, however, indicated the need of conducting fur-
ther observation of patients. 
Summary
The analysis of the literature on myocarditis in children from 
the last 5 years indicates that myocarditis is a rare disease, 
in the case of which two incidence peaks occur — in early 
infancy and in adolescents. In most cases, it is etiologically 
associated with either ongoing viral infection of the respira-
tory or gastrointestinal tract, or a history thereof, combined 
with cardiac symptoms that depend on the age of the child. 
According to the experts, the clinical image of myocarditis 
may resemble other cardiac diseases and takes the form 
of acute or chronic heart failure (occurring in patients who 
were not previously diagnosed with a cardiac disease), life-
-threatening arrhythmia (including sudden cardiac death) 
or a form resembling acute coronary syndrome [1]. In the 
analyzed groups of patients, younger children suffered 
from acute hear failure and dangerous arrhythmia, while 
in older children, the disease caused chest pain syndrome 
(with ST-T changes in ECG and elevated troponin level).
Initial diagnosis is made on the basis of clinical symp-
toms and results of additional examinations: myocardial 
damage markers, ECG, X-ray and ECHO. Elevated troponin 
levels are observed in most patients, while in children with 
symptoms of heart failure the level of NT-pro-BNP is also 
elevated. The number of myocardial biopsies has been 
decreasing in recent years. CMR is becoming the basis for 
the diagnosis of myocarditis.
Treatment involves mainly bed regime, pharmacolo-
gical treatment of heart failure and arrhythmia. Constant 
point-of-care monitoring of the heart rhythm in hospital 
conditions is necessary. Some patients with fulminant my-
ocarditis require mechanical circulatory support: ECMO, 
VAD and even heart transplant. Mortality rate is high, it 
reaches as much as 25–30%. At the acute stage of the 
disease, patients should be hospitalized. Later on, even 
if the signs of inflammation have subsided, they should 
remain under the care of a cardiologist. Due to the diver-
sity of clinical course of the disease, the applied diagno-
stic methods and definitions of the disease, it seems that 
the incidence of myocarditis in the population of children 
is underestimated.
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Streszczenie
Zapalenie mięśnia sercowego (ZMS) według Światowej Organizacji Zdrowia definiuje się jako chorobę zapalną obejmującą 
kardiomiocyty, tkankę śródmiąższową, naczynia, a czasem również osierdzie. W poniższym opracowaniu przeanalizowano 
piśmiennictwo z ostatnich 5 lat dotyczące epidemiologii, badań diagnostycznych, leczenia i rokowania w ZMS u dzieci 
i młodzieży. W tym celu dokonano przeglądu medycznej bazy danych Pubmed, używając słów/zwrotów kluczowych: „dzie-
ci” (ang. ‘children’), „zapalenie mięśnia sercowego” (ang. ‘myocarditis’) — strategia ta pozwoliła uzyskać łącznie 117 ar-
tykułów. Spośród nich wyodrębniono prace, w których badana grupa obejmowała co najmniej 5 dzieci, a w opisie zawarto 
dane dotyczące objawów klinicznych, odchyleń w badaniach laboratoryjnych oraz badaniach obrazowych, identyfikacji 
czynników etiologicznych, zastosowanego leczenia oraz czasu hospitalizacji i liczby zgonów. Do analizy końcowej włączo-
no 17 artykułów; zestawienie obejmuje łącznie 1891 dzieci, u których rozpoznano ZMS. Z analizy wynika, że ZMS jest 
chorobą rzadką. Obserwuje się dwa szczyty zachorowań: w wieku noworodkowym i wczesnoniemowlęcym oraz w okresie 
dojrzewania, przy czym wiek poniżej 2. rż. jest niekorzystnym czynnikiem rokowniczym. W raportowanych przypadkach 
najczęstszymi objawami podmiotowymi były: osłabienie, ból w klatce piersiowej, kołatania serca. Wśród objawów przed-
miotowych dominowały: tachypnoe, tachykardia, hipotensja, hepatomegalia. Wywiad, wynik badania przedmiotowego 
oraz wyniki badań dodatkowych (stężenia troponin, elektrokardiogram, echokardiogram) przybliżają do rozpoznania, 
natomiast „złotym standardem” do ustalenia diagnozy jest badanie rezonansu magnetycznego serca. W analizowanej 
grupie 65–90% dzieci wymagało leczenia na oddziale intensywnej terapii, u 168 dzieci zastosowano ciągłe pozaustrojowe 
natlenianie krwi, a 35 dzieciom wszczepiono tak zwane sztuczne komory. U 38 pacjentów wykonano przeszczepienie 
serca. Śmiertelność w ZMS jest wysoka (w przeanalizowanym piśmiennictwie wyniosła 25–35%). U około 25% dzieci dys-
funkcja mięśnia sercowego pozostała trwała. Ze względu na nieprzewidywalny przebieg choroby pacjent w ostrym okresie 
choroby powinien być hospitalizowany, a po wypisaniu ze szpitala podlegać dalszej kontroli kardiologicznej.
Słowa kluczowe: zapalenie mięśnia sercowego, niewydolność serca, dzieci, młodzież
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